XenoBR

Business Services · Brazil · 11-50 Employees

View Company Info for Free

Overview

Headquarters

106 Rua Do Matão, Sao Paulo, 05508-090, ...

Revenue

<$5 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About XenoBR

XenoBrasil is a startup focused on developing genetically modified pigs for xenotransplantation, addressing the shortage of organs for transplant in Brazil. The company collaborates with pharmaceutical firm EMS and leading researchers to advance this innovative solution. With significant investments from the government of São Paulo and partnerships with institutions like USP and MCTI, XenoBrasil aims to create compatible organs for human transplantation. Their research is positioned to generate the first piglets suitable for xenotransplantation in the Southern Hemisphere.Explore more
XenoBR's Social MediaPopular SearchesXenoBRSIC Code 87,873NAICS Code 54,541Show more

XenoBR Org Chart

Tadeu Thome, Chief Executive Officer at XenoBR
Brazil flag for contact location.

Chief Executive Officer

PhoneEmail
LB
Brazil flag for contact location.

Pesquisador Associado

PhoneEmail
ED
Brazil flag for contact location.

Pesquisador Associado

PhoneEmail
TB
Brazil flag for contact location.

Analista Laboratório De Pesquisa

PhoneEmail
MZ
Brazil flag for contact location.

Pesquisadora Associada

PhoneEmail
JC
Brazil flag for contact location.

Analista Científica Pleno - Bolsista DTI and ...

PhoneEmail
LL
Brazil flag for contact location.

Pesquisadora

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is XenoBR your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

XenoBR is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

XenoBR is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about XenoBR.

Top Business Services Companies

Frequently Asked Questions Regarding XenoBR

What is XenoBR's official website?
XenoBR's official website is xenotransplante.ib.usp.br
What is XenoBR's Revenue?
XenoBR's revenue is <$5 Million
What is XenoBR's SIC code?
XenoBR's SIC: 87,873
What is XenoBR's NAICS code?
XenoBR's NAICS: 54,541
How many employees does XenoBR have?
XenoBR has 11-50 employees
What industry does XenoBR belong to?
XenoBR is in the industry of: Business Services, Research & Development
What companies has XenoBR acquired?
XenoBR has acquired the companies: Ialumni
What does XenoBR do?

XenoBrasil is a startup focused on developing genetically modified pigs for xenotransplantation, addressing the shortage of organs for transplant in Brazil. The company collaborates with pharmaceutical firm EMS and leading researchers to advance this innovative solution. With significant investments from the government of São Paulo and partnerships... with institutions like USP and MCTI, XenoBrasil aims to create compatible organs for human transplantation. Their research is positioned to generate the first piglets suitable for xenotransplantation in the Southern Hemisphere.Read More

What are XenoBR social media links?
XenoBR Linkedin page
Is XenoBR a public company?
XenoBR is private company therefore does not currently have an official ticker symbol
See more information about XenoBR

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.